<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>T-cell receptor therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/t-cell-receptor-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 14 Oct 2026 13:17:00 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>T-cell receptor therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Scientists Map a Battle Plan Against One of Medicine&#8217;s Rarest and Deadliest Childhood Cancers</title>
		<link>https://bioengineer.org/scientists-map-a-battle-plan-against-one-of-medicines-rarest-and-deadliest-childhood-cancers/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 14 Oct 2026 13:17:00 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[androgen receptor]]></category>
		<category><![CDATA[antibody-drug conjugates]]></category>
		<category><![CDATA[B7-H3]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[DNA damage response]]></category>
		<category><![CDATA[Drug development]]></category>
		<category><![CDATA[DSRCT]]></category>
		<category><![CDATA[EWSR1::WT1 fusion]]></category>
		<category><![CDATA[paediatric oncology]]></category>
		<category><![CDATA[rare cancers]]></category>
		<category><![CDATA[sarcoma]]></category>
		<category><![CDATA[T-cell receptor therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=418965</guid>

					<description><![CDATA[An international expert workshop has prioritised targets and trial designs to break the three-decade therapeutic stalemate in desmoplastic small round cell tumour, an ultra-rare cancer with survival rates below 20 per cent.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">418965</post-id>	</item>
	</channel>
</rss>
